Powder: -20°C for 3 years
In solvent: -80°C for 2 years
NVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition; also shows activity against c-Raf, c-Src and c-Abl with IC50 of 0.395 μM, 1.266 μM and 1.667 μM, respectively.
Description | NVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition; also shows activity against c-Raf, c-Src and c-Abl with IC50 of 0.395 μM, 1.266 μM and 1.667 μM, respectively. |
Targets&IC50 | C-Raf:0.395 μM, c-Abl:1.667 μM, EphB4:25 nM, c-Src:1.266 μM |
Molecular Weight | 503.49 |
Formula | C26H20F3N7O |
CAS No. | 940310-85-0 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 24.7 mg/mL(40 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NVP-BHG712 940310-85-0 Angiogenesis Cytoskeletal Signaling MAPK Tyrosine Kinase/Adaptors Src Raf Ephrin Receptor Bcr-Abl BHG 712 inhibit Inhibitor NVP BHG712 NVPBHG712 BHG-712 BHG712 NVP-BHG-712 inhibitor